La variabilidad constitucional en genes de proliferación celular (ATBF1 y EP300) y de inmunidad innata (IRF-3, DEBF1) influye en el pronóstico clínico tras alotrasplante de progenitores hematopoyéticos (alo-TPH)

Published in 2010 by B. Martín-Antonio

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload